Wilmington, DE · Compounded Semaglutide
Compounded Semaglutide in Wilmington, DE — Telehealth Access from $86/mo
Ozari serves patients in Wilmington and across Delaware through licensed telehealth clinicians. Wilmington is Delaware's largest city and a major financial hub, home to the headquarters of numerous Fortune 500 companies and a professional population with strong healthcare expectations
Prescriptions are filled by Ozari's named 503A partners — Hallandale Pharmacy (PCAB-accredited) and VialsRx (USP 797 sterile compounding) — and shipped directly to your Delaware address.
Delaware's telehealth-friendly regulations allow Wilmington residents to access licensed GLP-1 prescriptions from board-certified physicians online, with medications delivered to their door
Compounded semaglutide and tirzepatide are prescribed for documented individual patient need by licensed physicians and prepared by licensed U.S. compounding pharmacies. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality.
Start Online Visit
Quick Answer
Compounded semaglutide is a pharmacy-prepared prescription, not an FDA-approved Wegovy product. Wilmington residents can complete Ozari's online intake, receive physician review, and have medication shipped home with plans from $86/month on the Starter tier when clinically appropriate.
Published pricing for Wilmington patients
All plans below are sourced from Ozari's current treatment pricing. No insurance required.
Tap to switch plan type
$257 billed every 3 months
Save $268
Pricing last verified: July 28, 2026
Branded comparison: Retail pharmacy cash pricing for branded Wegovy often exceeds $1,000 per month without manufacturer programs. Through NovoCare self-pay, Wegovy is listed at $199 per month for the first two qualifying fills, then $349 per month for standard doses under current manufacturer terms — verify NovoCare before comparing.
Telehealth access for Delaware patients
Delaware requires health insurers to cover telehealth services on par with in-person care, and the state has adopted Medicaid telehealth expansion policies that extend to weight management consultations. The Delaware Medical Practice Act permits physicians to establish patient relationships via synchronous video, making it fully legal for Ozari-affiliated physicians to prescribe compounded medications to Delaware residents without a prior in-person visit.
How Ozari's process works
A physician-led workflow for Wilmington residents who want transparent pricing and named pharmacy partners.
Step 1
Complete your online intake
Answer structured health questions from anywhere in Delaware. Most patients finish in under 10 minutes.
Step 2
Physician review and eligibility decision
A licensed clinician reviews your history, contraindications, and goals before any prescription is written.
Step 3
Pharmacy fulfillment and home delivery
If prescribed, your order is prepared by a licensed 503A partner pharmacy and shipped to your Delaware address with cold-chain packaging when required.
Step 4
Ongoing clinical support
Message your care team for titration questions, side effects, and refills instead of navigating clinic phone trees.
Named pharmacy partners
Ozari does not sell semaglutide from inventory. Every order is patient-specific, written by a licensed prescriber, and prepared by either Hallandale Pharmacy — a PCAB-accredited 503A facility in Fort Lauderdale, Florida — or VialsRx, a U.S.-licensed 503A pharmacy compounding under USP 797 standards. Your shipment label identifies the dispensing pharmacy. Ozari Health holds LegitScript certification for its telehealth platform, which third parties can verify independently.
Hallandale Pharmacy
PCAB-accredited 503A compounding pharmacy in Fort Lauderdale, Florida
VialsRx
U.S.-licensed 503A compounding pharmacy operating under USP 797 sterile compounding standards
Frequently asked questions
Common questions from Wilmington patients considering compounded semaglutide.
Compounded semaglutide is prepared by a licensed 503A pharmacy for an individual prescription. Branded Wegovy is an FDA-approved finished product with a full FDA review of safety, efficacy, and manufacturing. Compounded versions are not FDA-approved, not generic equivalents, and are prescribed only when a licensed clinician determines they are appropriate for your history.
Ozari publishes flat-rate plans for Wilmington, Delaware: $86/month equivalent on the 3-Month Starter Plan ($257 every 3 months, first-time GLP-1 users), $145/month on Quarterly ($435 every 3 months), or $175/month month-to-month. Free shipping is included; no insurance is required.
Safety depends on appropriate prescribing, pharmacy standards, and follow-up care — not price alone. Ozari uses named 503A partners (Hallandale Pharmacy, PCAB-accredited; VialsRx, USP 797) and a LegitScript-certified telehealth platform. Compounded products are still not FDA-approved finished drugs, so your clinician must review contraindications before treatment.
You complete a secure online intake, a licensed clinician reviews your record, and a prescription is sent to a 503A partner pharmacy only if treatment is medically appropriate. Medication ships to your Wilmington, Delaware address. There is no checkout without clinician review.
In STEP 1 (NEJM 2021), FDA-approved semaglutide 2.4 mg with lifestyle support produced a mean 14.9% body weight reduction at 68 weeks versus 2.4% with placebo. Published trial averages are not guarantees for compounded products or for any individual patient.
Delaware requires health insurers to cover telehealth services on par with in-person care, and the state has adopted Medicaid telehealth expansion policies that extend to weight management consultations. The Delaware Medical Practice Act permits physicians to establish patient relationships via synchronous video, making it fully legal for Ozari-affiliated physicians to prescribe compounded medications to Delaware residents without a prior in-person visit.
Ozari routes prescriptions to Hallandale Pharmacy (PCAB-accredited 503A, Fort Lauderdale, FL) or VialsRx (U.S.-licensed 503A, USP 797). Your vial label and patient materials identify the dispensing pharmacy for that shipment.
Yes. Eligible Wilmington, Delaware patients receive free expedited shipping to residential or business addresses statewide once a prescription is approved and filled. Cold-chain packaging is used when required for medication stability in transit.
Ready to start in Wilmington?
Complete your intake online. A licensed clinician reviews your information before any prescription is written.
Start Online Visit